Longitudinal Patient Outcomes in Chronic Dizziness : A Scoping Review
Copyright © 2023, Otology & Neurotology, Inc..
BACKGROUND: Chronic dizziness can cause significant functional impairment. Outcome measures used in this patient population have not been examined systematically. Consequently, providers lack consensus on the ideal outcome measures to assess the impact of their interventions.
OBJECTIVE AND METHODS: We conducted a scoping review to summarize existing literature on outcomes in chronic dizziness (with a minimum of 6 mo of patient follow-up). Among other details, we extracted and analyzed patient demographics, medical condition(s), and the specific outcome measures of each study.
RESULTS: Of 19,426 articles meeting the original search terms, 416 met final exclusion after title/abstract and full-text review. Most studies focused on Ménière's disease (75%) and recurrent benign paroxysmal positional vertigo (21%). The most common outcome measures were hearing (62%) and number of attacks by American Academy of Otolaryngology-Head & Neck Surgery criteria (60%). A minority (35%) looked formally at quality-of-life metrics (Dizziness Handicap Index or other).
CONCLUSIONS: Ménière's disease and benign paroxysmal positional vertigo are overrepresented in literature on outcome assessment in chronic dizziness. Objective clinical measures are used more frequently than quality-of-life metrics. Future work is needed to identify the optimal outcome measures that reflect new knowledge about the most common causes of chronic dizziness (including persistent postural-perceptual dizziness and vestibular migraine) and consider what is most important to patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology - 44(2023), 9 vom: 01. Okt., Seite 848-852 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Canturk, Toros [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 15.09.2023 Date Revised 07.10.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1097/MAO.0000000000004000 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362011885 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362011885 | ||
| 003 | DE-627 | ||
| 005 | 20231226090341.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/MAO.0000000000004000 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1206.xml |
| 035 | |a (DE-627)NLM362011885 | ||
| 035 | |a (NLM)37703893 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Canturk, Toros |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Longitudinal Patient Outcomes in Chronic Dizziness |b A Scoping Review |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.09.2023 | ||
| 500 | |a Date Revised 07.10.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023, Otology & Neurotology, Inc. | ||
| 520 | |a BACKGROUND: Chronic dizziness can cause significant functional impairment. Outcome measures used in this patient population have not been examined systematically. Consequently, providers lack consensus on the ideal outcome measures to assess the impact of their interventions | ||
| 520 | |a OBJECTIVE AND METHODS: We conducted a scoping review to summarize existing literature on outcomes in chronic dizziness (with a minimum of 6 mo of patient follow-up). Among other details, we extracted and analyzed patient demographics, medical condition(s), and the specific outcome measures of each study | ||
| 520 | |a RESULTS: Of 19,426 articles meeting the original search terms, 416 met final exclusion after title/abstract and full-text review. Most studies focused on Ménière's disease (75%) and recurrent benign paroxysmal positional vertigo (21%). The most common outcome measures were hearing (62%) and number of attacks by American Academy of Otolaryngology-Head & Neck Surgery criteria (60%). A minority (35%) looked formally at quality-of-life metrics (Dizziness Handicap Index or other) | ||
| 520 | |a CONCLUSIONS: Ménière's disease and benign paroxysmal positional vertigo are overrepresented in literature on outcome assessment in chronic dizziness. Objective clinical measures are used more frequently than quality-of-life metrics. Future work is needed to identify the optimal outcome measures that reflect new knowledge about the most common causes of chronic dizziness (including persistent postural-perceptual dizziness and vestibular migraine) and consider what is most important to patients | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Bery, Anand K |e verfasserin |4 aut | |
| 700 | 1 | |a Piccoli, David |e verfasserin |4 aut | |
| 700 | 1 | |a Pyche, Jacob |e verfasserin |4 aut | |
| 700 | 1 | |a Czikk, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Osborne, Jake |e verfasserin |4 aut | |
| 700 | 1 | |a Pearson, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Bhatt, Chirayu |e verfasserin |4 aut | |
| 700 | 1 | |a Shin, John |e verfasserin |4 aut | |
| 700 | 1 | |a Chow, Linda |e verfasserin |4 aut | |
| 700 | 1 | |a Azzi, Jayson Lee |e verfasserin |4 aut | |
| 700 | 1 | |a Tohme, Angelina |e verfasserin |4 aut | |
| 700 | 1 | |a Caulley, Lisa |e verfasserin |4 aut | |
| 700 | 1 | |a Lelli, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Tse, Darren |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology |d 2001 |g 44(2023), 9 vom: 01. Okt., Seite 848-852 |w (DE-627)NLM11209144X |x 1537-4505 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2023 |g number:9 |g day:01 |g month:10 |g pages:848-852 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/MAO.0000000000004000 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2023 |e 9 |b 01 |c 10 |h 848-852 | ||